While the initial GLP-1 MDL (MDL 3094) focuses extensively on systemic gastrointestinal injuries, such as gastroparesis, bowel obstructions, and ileus, the distinct medical, scientific, and causation arguments surrounding blindness and optic nerve damage required a targeted management framework
Rare but serious side effects have been reported, including liver injury and kidney stones (oxalate nephropathy)
Download Glowiseyour AI partner for calories, nutrition, GLP-1 support, and real progress
No solo endocrinos, un abordaje interdisciplinar es el que marca el xito porque sabemos que la obesidad es una enfermedad crnica y recurrente y tenemos que ayudar al paciente, acompaarle y por supuesto quitarle el estigma: no padece obesidad porque quiere
GLP-1 Drugs and Sensory Side Effects: Understanding New Reports of Dysesthesia and Allodynia A new medical report is highlighting a potential, though rare, side effect associated with popular GLP-1 receptor agonist medications like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound)
Phentermine Theres no one-size-fits-all answer